Pseudomonas Infections - 25 Studies Found

Completed : Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin
: Pseudomonas Infections
: 2008-03-04
:
  • Drug: tobramycin 1x300mg/d inh
Completed : Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa
:
  • Pseudomonas Aeruginosa
  • Ventilator Associated Pneumonia
    • : 2008-06-03
    :
    • Biological: KB001 Single low-d
Completed : Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections
: Pseudomonas Aeruginosa Infection
: 2011-03-14
:
  • Drug: Liposomal amikacin for inhalation (Arikayce) using the PARI Investigat
Completed : Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection
: Bronchiectasis With Chronic Infection With Pseudomonas Aeruginosa
: 2014-03-06
: Drug: Tobramycin
Completed : Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
:
  • Cystic Fibrosis
  • Pseudomonas Aeruginosa

: 2011-07-26
: Drug: AZLI AZLI 75 mg was administered 3 times daily via the investigational nebulizer.
Completed : Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization
:
  • Cystic Fibrosis
  • Pseudomonas Aeruginosa

: 2009-12-17
: Drug: Colistin Sino-Nasal inhalation, approximately 1 ml / day in each nostril
Completed : Cipro Inhaler for Cystic Fibrosis Children Ages 6-12
: Pseudomonas Infection
: 2009-05-28
: Drug: Ciprofloxacin (Cipro, BAYQ3939) 25 mg inhaled Ciprofloxacin
Completed : Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers
: Healthy
: 2008-10-22
:
  • Biological: IC43 The study con
Terminated : Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa
: Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis
: 2014-09-22
: Drug: TIS or TIP 300mg nebulized Tobramycin (Tobramycin inhalation solution(TIS)) or TOBI Podhaler (Tobr
Approved for marketing : Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection
:
  • Cystic Fibrosis
  • Pseudomonas Aeruginosa Airway Infection
    • : 2007-07-09
    : Drug: Aztreonam Lysine for Inhalation 75 mg three times a day via inhalation for 28 days followed by 28
<<< Previous | Next >>>